192 related articles for article (PubMed ID: 15289488)
1. American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays.
Schrag D; Garewal HS; Burstein HJ; Samson DJ; Von Hoff DD; Somerfield MR;
J Clin Oncol; 2004 Sep; 22(17):3631-8. PubMed ID: 15289488
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays.
Burstein HJ; Mangu PB; Somerfield MR; Schrag D; Samson D; Holt L; Zelman D; Ajani JA;
J Clin Oncol; 2011 Aug; 29(24):3328-30. PubMed ID: 21788567
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin use in oncology: a summary of the evidence and practice guidelines comparing efforts of the Cochrane Review group and Blue Cross/Blue Shield to set up the ASCO/ASH guidelines.
Djulbegovic B
Best Pract Res Clin Haematol; 2005; 18(3):455-66. PubMed ID: 15792920
[TBL] [Abstract][Full Text] [Related]
4. Practical guidelines for diagnostic use of in vitro chemosensitivity tests.
Schinköthe T; Haeger S; Gabri MR
Anticancer Res; 2007; 27(3A):1365-7. PubMed ID: 17593632
[TBL] [Abstract][Full Text] [Related]
5. American Society of Clinical Oncology clinical practice guidelines: opportunities and challenges.
Somerfield MR; Einhaus K; Hagerty KL; Brouwers MC; Seidenfeld J; Lyman GH;
J Clin Oncol; 2008 Aug; 26(24):4022-6. PubMed ID: 18711193
[TBL] [Abstract][Full Text] [Related]
6. The ASH/ASCO clinical guidelines on the use of erythropoietin.
Lichtin A
Best Pract Res Clin Haematol; 2005; 18(3):433-8. PubMed ID: 15792917
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy sensitivity and response assays: are the ASCO guidelines for clinical trial design too restrictive?
Wieand HS
J Clin Oncol; 2005 May; 23(15):3643-4; author reply 3646-8. PubMed ID: 15908687
[No Abstract] [Full Text] [Related]
8. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
[TBL] [Abstract][Full Text] [Related]
9. A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative.
Neuss MN; Desch CE; McNiff KK; Eisenberg PD; Gesme DH; Jacobson JO; Jahanzeb M; Padberg JJ; Rainey JM; Guo JJ; Simone JV
J Clin Oncol; 2005 Sep; 23(25):6233-9. PubMed ID: 16087948
[TBL] [Abstract][Full Text] [Related]
10. Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty.
Wasif N; Ye X; Giuliano AE
Ann Surg Oncol; 2009 Sep; 16(9):2442-9. PubMed ID: 19506955
[TBL] [Abstract][Full Text] [Related]
11. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
Cookson MS; Aus G; Burnett AL; Canby-Hagino ED; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen C; Thrasher JB; Thompson I
J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629
[TBL] [Abstract][Full Text] [Related]
12. An introduction to an evidence-based approach to interventional techniques in the management of chronic spinal pain.
Manchikanti L; Singh V; Helm S; Schultz DM; Datta S; Hirsch JA;
Pain Physician; 2009; 12(4):E1-33. PubMed ID: 19668280
[TBL] [Abstract][Full Text] [Related]
13. Developing an in-training examination for fellows: the experience of the American Society of Clinical Oncology.
Collichio FA; Kayoumi KM; Hande KR; Hawkins RE; Hawley JL; Adelstein DJ; D'Angelo JM; Stewart JA
J Clin Oncol; 2009 Apr; 27(10):1706-11. PubMed ID: 19224843
[TBL] [Abstract][Full Text] [Related]
14. Publication outcomes of phase II oncology clinical trials.
Hoeg RT; Lee JA; Mathiason MA; Rokkones K; Serck SL; Crampton KL; Emmel AE; Severson EA; Go RS
Am J Clin Oncol; 2009 Jun; 32(3):253-7. PubMed ID: 19349853
[TBL] [Abstract][Full Text] [Related]
15. American Society Of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards.
Jacobson JO; Polovich M; McNiff KK; Lefebvre KB; Cummings C; Galioto M; Bonelli KR; McCorkle MR; ;
J Clin Oncol; 2009 Nov; 27(32):5469-75. PubMed ID: 19786650
[TBL] [Abstract][Full Text] [Related]
16. American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards.
Jacobson JO; Polovich M; McNiff KK; LeFebvre KB; Cummings C; Galioto M; Bonelli KR; McCorkle MR; ;
Oncol Nurs Forum; 2009 Nov; 36(6):651-8. PubMed ID: 19887353
[TBL] [Abstract][Full Text] [Related]
17. Where does hematology end and oncology begin? Questions of professional boundaries and medical authority.
Krueger G; Canellos G
J Clin Oncol; 2006 Jun; 24(16):2583-8. PubMed ID: 16735712
[TBL] [Abstract][Full Text] [Related]
18. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
19. Revisions to the 2009 American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards: expanding the scope to include inpatient settings.
Jacobson JO; Polovich M; Gilmore TR; Schulmeister L; Esper P; Lefebvre KB; Neuss MN
Oncol Nurs Forum; 2012 Jan; 39(1):31-8. PubMed ID: 22201653
[TBL] [Abstract][Full Text] [Related]
20. The blue cross blue shield assessment technology review: summary of findings.
Bennett CL
Best Pract Res Clin Haematol; 2005; 18(3):423-31. PubMed ID: 15792916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
